A novel coronavirus outbreak of global health concern.

PubWeight™: 4.85‹?› | Rank: Top 1%

🔗 View Article (PMID 31986257)

Published in Lancet on January 24, 2020


Chen Wang1, Peter W Horby2, Frederick G Hayden3, George F Gao4

Author Affiliations

1: Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China; National Clinical Research Center for Respiratory Diseases, Beijing, China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China. Electronic address: cyh-birm@263.net.
2: Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
3: Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
4: National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.

Associated clinical trials:

Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19 | NCT04316728

Ivermectin and Nitazoxanide Combination Therapy for COVID-19 | NCT04360356

Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19 | NCT04361318

Atorvastatin as Adjunctive Therapy in COVID-19 (STATCO19) | NCT04380402

Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress (AGMFMSS) | NCT04443075

Psychiatric Disturbances and COVID-19 Infection | NCT04459403